GlaxoSmithKline (GSK) option implied volatility low

GlaxoSmithKline (NYSE: GSK) December weekly call option implied volatility is at December is at , January is at ; compared to its 52-week range of 14 to 30 after ArQule (ARQL) was acquired by Merck (MRK) for $2.7B and Synthorx (THOR) was purchased by Sanofi (SNY) for $2.5B. J.P. Morgan 38th Annual Healthcare Conference begins January 13, 2020.

You May Also Be Interested In

• Micron Technology (MU) call put ratio 1.4 calls to 1 put on 1.2M contracts as share price up 4%
• Meta Platforms (META) call put ratio 1.2 calls to 1 put on 960K contracts
• Viking (VIK) call put ratio 1.7 calls to 1 put into quarter results